Jarrod Longocor

Company: Cellectar Biosciences

Job title: Chief Business Officer

Seminars:

Moving Beyond Solid Tumors: A Novel Radiotherapy in Hematologic Cancers 2:00 pm

Understanding Phospholipid ethers (PLE)s as a novel radioconjungate platform (PRCs) Review of Bexxar and Zevalin in hematologic cancers: Successes and challenges Highlights of PRCs data and methods to overcome challengesRead more

day: Day One